These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19603244)

  • 1. Requirements for generic anti-epileptic medicines: a regulatory perspective.
    Maliepaard M; Hekster YA; Kappelle A; van Puijenbroek EP; Elferink AJ; Welink J; Gispen-de Wied CC; Lekkerkerker FJ
    J Neurol; 2009 Dec; 256(12):1966-71. PubMed ID: 19603244
    [No Abstract]   [Full Text] [Related]  

  • 2. Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy.
    Liow K; Barkley GL; Pollard JR; Harden CL; Bazil CW;
    Neurology; 2007 Apr; 68(16):1249-50. PubMed ID: 17438213
    [No Abstract]   [Full Text] [Related]  

  • 3. What's the problem with generic antiepileptic drugs?: a call to action.
    Berg MJ
    Neurology; 2007 Apr; 68(16):1245-6. PubMed ID: 17438211
    [No Abstract]   [Full Text] [Related]  

  • 4. The cost of gullibility.
    Roach ES
    Arch Neurol; 2009 Nov; 66(11):1418-20. PubMed ID: 19901178
    [No Abstract]   [Full Text] [Related]  

  • 5. Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial.
    Privitera MD; Welty TE; Gidal BE; Diaz FJ; Krebill R; Szaflarski JP; Dworetzky BA; Pollard JR; Elder EJ; Jiang W; Jiang X; Berg M
    Lancet Neurol; 2016 Apr; 15(4):365-72. PubMed ID: 26875743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Wiberg CC
    Neurology; 2005 Apr; 64(8):1485-6; author reply 1485-6; discussion 1485-6. PubMed ID: 15851759
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioequivalence of antiepileptic drugs: how close is close enough?
    Gidal BE
    Curr Neurol Neurosci Rep; 2009 Jul; 9(4):333-7. PubMed ID: 19515287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are generic drugs really inferior medicines?
    Moore N; Berdaï D; Bégaud B
    Clin Pharmacol Ther; 2010 Sep; 88(3):302-4. PubMed ID: 20725079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is bioavailability altered in generic versus brand anticonvulsants?
    Jankovic SM; Ignjatovic Ristic D
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):329-32. PubMed ID: 25440299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Debate: Substitution of generic drugs in epilepsy: is there cause for concern?
    Gidal BE; Tomson T
    Epilepsia; 2008 Dec; 49 Suppl 9():56-62. PubMed ID: 19087118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generic antiepileptic drugs-Safe or harmful in patients with epilepsy?
    Holtkamp M; Theodore WH
    Epilepsia; 2018 Jul; 59(7):1273-1281. PubMed ID: 29894004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antiepileptic drug substitutions on epileptic events requiring acute care.
    Rascati KL; Richards KM; Johnsrud MT; Mann TA
    Pharmacotherapy; 2009 Jul; 29(7):769-74. PubMed ID: 19558250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More data on the safety of generic substitution: Yes, the blue tablet is OK?
    Krauss GL; Privitera M
    Neurology; 2016 Oct; 87(17):1754-1755. PubMed ID: 27683849
    [No Abstract]   [Full Text] [Related]  

  • 14. Requirements for generic antiepileptic medicines: a clinical perspective.
    Trinka E; Krämer G; Graf M
    J Neurol; 2011 Dec; 258(12):2128-32. PubMed ID: 21667222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generic substitution of antiepileptic medications in patients with epilepsy: is this a potential problem?
    Gauthier-Lewis M; Riley TT
    Am J Health Syst Pharm; 2009 Nov; 66(21):1903-4. PubMed ID: 19850781
    [No Abstract]   [Full Text] [Related]  

  • 16. Generic substitution of antiepileptic drugs.
    Sander JW; Ryvlin P; Stefan H; Booth DR; Bauer J
    Expert Rev Neurother; 2010 Dec; 10(12):1887-98. PubMed ID: 21091318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generic prescribing in epilepsy.
    Drug Ther Bull; 2009 Dec; 47(12):141-4. PubMed ID: 20009042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generic medications: another variable in the treatment of illnesses.
    Blier P
    J Psychopharmacol; 2007 Jul; 21(5):459-60. PubMed ID: 17664245
    [No Abstract]   [Full Text] [Related]  

  • 19. The safety of generic substitution in epilepsy.
    Perucca E
    Lancet Neurol; 2016 Apr; 15(4):344-5. PubMed ID: 26875742
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiepileptic drugs: the drawbacks of generic substitution.
    Lancet Neurol; 2010 Mar; 9(3):227. PubMed ID: 20170834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.